Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

StemCell Technologies Inc.

www.stemcell.com

Latest From StemCell Technologies Inc.

Tech Transfer Roundup: Vanderbilt Teams With Deerfield; Expands Cancer Pact With Boehringer

Vanderbilt launches new biotech with Deerfield aimed at reworking the drug development paradigm, while also expanding its cancer research work with BI. Grunenthal partners with Katholieke Universiteit Leuven to investigate ion channel modulation approaches in pain.

Research & Development Deals

GE Healthcare Embraces Solutions Role In Growing Regen Med Sector

GE Healthcare’s Life Sciences business continues to build its asset base in the cell and gene therapy sector, and after several strategic M&A deals in recent months is facing 2017 in a confident mood, according to Phil Vanek, cell therapy growth leader.

Business Strategies Growth

Tech Transfer Deals, May 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Tech Transfer Deals column provides a monthly update on technology transfer deals, reporting licensing agreements between companies and universities or other research institutions within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced March through April 2016.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • StemCell Technologies Inc.
  • Senior Management
  • Allen Eaves, Pres. & CEO
  • Contact Info
  • StemCell Technologies Inc.
    Phone: (604) 877-0713
    1618 Station St.
    Vancouver, V6A 1B6
    Canada
Advertisement
Advertisement
UsernamePublicRestriction

Register